Alaska 33rd Legislature (2023-2024) Status: Enacted Bipartisan · 2 R · 2 I · 1 D cosponsors

HB 226 — An Act relating to insurance; relating to pharmacy benefits managers; relating to dispensing fees; and providing for an effective date.

Last action — (H) EFFECTIVE DATE(S) OF LAW SEE CHAPTER

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 16, 2024. Enacted.

Signed by Governor Mike Dunleavy (Republican) on October 09, 2024.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 82% · high confidence
  • Enacted

    Current position in the legislative process.

  • 8 sponsors

    1 primary, 7 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 3 parties (2 R · 2 I · 1 D) — cross-party backing.

  • Mixed recorded votes

    4 passed, 9 failed in recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

375 added · 558 removed

Plain-language change summary

In the updated version of Bill HB 226, the definition of "pharmacy benefits manager" has been clarified to ensure it aligns with a specific legal reference. Additionally, the requirements for a pharmacy benefits manager to do business in Alaska have shifted from needing registration as a third-party administrator to a more streamlined process. These changes are important because they aim to simplify regulations, potentially making it easier for pharmacy benefits managers to operate while also ensuring that they meet necessary standards for oversight and accountability.

→
Previous
Latest
33-LS0955\B HOUSE BILL NO.
LAWS OF ALASKA Source Chapter No.
226 IN THE LEGISLATURE OF THE STATE OF ALASKA THIRTY-THIRD LEGISLATURE - SECOND SESSION BY REPRESENTATIVES SUMNER, Himschoot, Ortiz, Wright, Ruffridge, Galvin, Josephson Introduced:
SCS CSHB 226(L&C) _______ AN ACT Relating to insurance;
1/16/24 Referred:
Health and Social Services, Labor and Commerce A BILL FOR AN ACT ENTITLED "An Act relating to the Board of Pharmacy;
relating to insurance;
relating to pharmacies;
relating to pharmacists;
relating to patient choice of pharmacy;
relating to dispensing fees;
and providing for an effective date." BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF ALASKA:
and providing for an effective date.
* Section 1.
_______________ BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF ALASKA:
AS 08.80.030(b) is amended to read:
THE ACT FOLLOWS ON PAGE 1 Enrolled HB 226 AN ACT Relating to insurance;
(b) In order to fulfill its responsibilities, the board has the powers necessary for implementation and enforcement of this chapter, including the power to (1) elect a president and secretary from its membership and adopt rules for the conduct of its business;
relating to pharmacy benefits managers;
(2) license by examination or by license transfer the applicants who are qualified to engage in the practice of pharmacy;
relating to dispensing fees;
(3) assist the department in inspections and investigations for violations of this chapter, or of any other state or federal statute relating to the practice of pharmacy;
and providing for an effective date.
HB0226a -1- HB 226 New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B (4) adopt regulations to carry out the purposes of this chapter;
_______________ * Section 1.
(5) establish and enforce compliance with professional standards and rules of conduct for pharmacists engaged in the practice of pharmacy;
AS 08.80.297(d)(2) is amended to read:
(6) determine standards for recognition and approval of degree programs of schools and colleges of pharmacy whose graduates shall be eligible for licensure in this state, including the specification and enforcement of requirements for practical training, including internships;
(2) "pharmacy benefits manager" has the meaning given in AS 21.27.975 [AS 21.27.955].
(7) establish for pharmacists and pharmacies minimum specifications for the physical facilities, technical equipment, personnel, and procedures for the storage, compounding, and dispensing of drugs or related devices, and for the monitoring of drug therapy, including independent monitoring of drug therapy;
(8) enforce the provisions of this chapter relating to the conduct or competence of pharmacists practicing in the state, and the suspension, revocation, or restriction of licenses to engage in the practice of pharmacy;
(9) license and regulate the training, qualifications, and employment of pharmacy interns and pharmacy technicians;
(10) license and regulate the qualifications of entities and individuals engaged in the manufacture or distribution of drugs and related devices;
(11) establish and maintain a controlled substance prescription database as provided in AS 17.30.200;
(12) establish standards for the independent prescribing and administration of vaccines and related emergency medications under AS 08.80.168, including the completion of an immunization training program approved by the board and an epinephrine auto-injector training program under AS 17.22.020(b);
(13) establish standards for the independent prescribing and dispensing by a pharmacist of an opioid overdose drug under AS 17.20.085, including the completion of an opioid overdose training program approved by the board;
(14) require that a licensed pharmacist who dispenses a schedule II, III, or IV controlled substance under federal law to a person in the state register with the controlled substance prescription database under AS 17.30.200(n);
(15) establish the qualifications and duties of the executive HB 226 -2- HB0226a New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B administrator and delegate authority to the executive administrator that is necessary to conduct board business;
(16) license and inspect the facilities of pharmacies, manufacturers, wholesale drug distributors, third-party logistics providers, and outsourcing facilities located outside the state under AS 08.80.159;
(17) license Internet-based pharmacies providing services to residents in the state;
(18) adopt regulations pertaining to retired pharmacist status;
(19) for a prescription drug that the United States Food and Drug Administration or the prescription drug's manufacturer has not approved for self-administration, prohibit, limit, or provide conditions relating to the dispensing of the prescription drug, including establishing specifications to ensure the effectiveness and security of a prescription drug to be administered by infusion or otherwise administered in a clinical setting.
AS 21.27.901 is amended by adding a new subsection to read:
AS 21.27.901 is amended to read:
(c) Each day that a pharmacy benefits manager conducts business in the state as a pharmacy benefits manager without being registered as required by (a) of this section is a separate violation of this section.
Sec.
21.27.901.
Registration of pharmacy benefits managers;
scope of business practice.
(a) A person may not conduct business in the state as a pharmacy benefits manager unless the person is registered with the director [AS A THIRD- PARTY ADMINISTRATOR UNDER AS 21.27.630].
(b) A pharmacy benefits manager registered under this section [AS 21.27.630] may (1) contract with an insurer to administer or manage pharmacy benefits -1- Enrolled HB 226 provided by an insurer for a covered person, including claims processing services for and audits of payments for prescription drugs and medical devices and supplies;
and (2) contract with network pharmacies [;
(3) SET THE COST OF MULTI-SOURCE GENERIC DRUGS UNDER AS 21.27.945;
AND (4) ADJUDICATE APPEALS RELATED TO MULTI-SOURCE GENERIC DRUG REIMBURSEMENT].
Show all 256 changed rows (216 more)
Previous
Latest
AS 21.27.901 is amended by adding new subsections to read:
(c) A pharmacy benefits manager (1) shall apply for registration following the same procedures for licensure set out in AS 21.27.040;
(2) is subject to hearings and orders on violations;
denial, nonrenewal, suspension, or revocation of registration;
penalties;
and surrender of registration under the procedures set out in AS 21.27.405 - 21.27.460.
(d) Each day that a pharmacy benefits manager conducts business in the state as a pharmacy benefits manager without being registered is a separate violation of this section, and each separate violation is subject to the maximum civil penalty under AS 21.97.020.
* Sec.
4.
AS 21.27.905(a) is amended to read:
(a) A pharmacy benefits manager shall biennially renew a registration with the director following the procedures for license renewal in AS 21.27.380.
* Sec.
5.
AS 21.27 is amended by adding a new section to read:
Sec.
21.27.907.
Duty of care.
(a) A pharmacy benefits manager owes a duty of care to a plan sponsor, benefits administrator, and covered person.
A pharmacy benefits manager shall adhere to the practices set out in this section.
(b) A pharmacy benefits manager shall (1) perform the manager's duties with care, skill, prudence, diligence, fairness, transparency, and professionalism and in the best interest of the plan sponsor, benefits administrator, and covered person as required by this section;
and (2) notify the plan sponsor in writing of any activity, policy, or practice of the pharmacy benefits manager that directly or indirectly presents any conflict of Enrolled HB 226 -2- interest with the duties imposed by this chapter.
(c) The duty of care owed to a covered person under this section takes precedence over the duty of care owed to any other person.
(d) A pharmacy benefits manager that receives from a drug manufacturer or labeler a payment or benefit of any kind in connection with the use of a prescription drug by a covered person, including a payment or benefit based on volume of sales or market share, shall pass that payment or benefit on in full to the plan sponsor.
(e) Upon request by a plan sponsor, a pharmacy benefits manager shall (1) provide information showing the quantity of drugs purchased by the covered person and the net cost to the covered person for the drugs;
the information must include all rebates, discounts, and other similar payments;
if requested by the plan sponsor, the pharmacy benefits manager shall provide the quantity and net cost information on a drug-by-drug basis by national drug code registration number rather than on an aggregated basis;
and (2) disclose to the plan sponsor all financial terms and arrangements for remuneration of any kind that apply between the pharmacy benefits manager and a prescription drug manufacturer or labeler, including formulary management and drug- substitution programs, educational support, claims processing, and data sales fees.
(f) A pharmacy benefits manager providing information to a plan sponsor under (e) of this section may designate that information as confidential.
Information designated as confidential may not be disclosed by the plan sponsor to another person without the consent of the pharmacy benefits manager, unless ordered by a court.
(g) If a pharmacy dispenses a substitute prescription drug for a prescribed drug to a covered person and the substitute prescription drug costs more than the prescribed drug, the pharmacy benefits manager shall disclose to the plan sponsor the cost of both drugs and any benefit or payment directly or indirectly accruing to the pharmacy benefits manager as a result of the substitution.
The pharmacy benefits manager shall transfer in full to the plan sponsor a benefit or payment received in any form by the pharmacy benefits manager as a result of a prescription drug substitution.
* Sec.
6.
AS 21.27.940 is amended to read:
Sec.
21.27.940.
Pharmacy audits;
restrictions.
The requirements of -3- Enrolled HB 226 AS 21.27.901 - 21.27.975 [21.27.955] do not apply to an audit (1) in which suspected fraudulent activity or other intentional or wilful misrepresentation is evidenced by a physical review, a review of claims data, a statement, or another investigative method;
or (2) of claims paid for under the medical assistance program under AS 47.07.
* Sec.
7.
(5) [(4)] review and update [APPLICABLE] list information at least once every seven [BUSINESS] days to ensure [REFLECT MODIFICATION OF] list HB0226a -3- HB 226 New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B pricing reflects current national drug database pricing;
(5) [(4)] review and update applicable list information at least once every seven business days to reflect modification of list pricing;
4.
8.
(b) Before placing or maintaining a specific drug on the list, a pharmacy benefits manager shall ensure that (1) if the drug is therapeutically equivalent and pharmaceutically equivalent to a prescribed drug, the drug is listed as thertically equivalent and pharmaceutically equivalent "A" or "B" rated in the most recent edition or supplement of the United States Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations, also known as the Orange Book;
(b) Before placing or maintaining a specific drug on the list, a pharmacy benefits manager shall ensure that (1) if the drug is therapeutically equivalent and pharmaceutically equivalent to a prescribed drug, the drug is listed as ttically equivalent and pharmaceutically equivalent "A" or "B" rated in the most recent edition or supplement of the United States Food and Drug Administration's Approved Drug Products with Enrolled HB 226 -4- Therapeutic Equivalence Evaluations, also known as the Orange Book;
(3) the drug is readily available for purchase by each pharmacy in the state from national or regional wholesalers operating in the state;
(3) the drug is readily available for purchase from national or regional wholesalers operating in the state;
5.
9.
and (3) specify for each drug (A) the national drug code;
(3) specify for each drug (A) the national drug code;
and (D) the reimbursement amount.
and (D) the reimbursement amount;
HB 226 -4- HB0226a New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B (d) In this section, (1) "interchangeable biological product" has the meaning given in AS 08.80.480;
and (4) specify the date on which a drug is added to or removed from the list.
(d) In this section, (1) "interchangeable biological product" has the meaning given in AS 08.80.480;
(3) "significant price update or modification" means (A) an increase of 10 percent or more in the pharmacy acquisition cost from 60 percent or more of the pharmaceutical wholesalers doing business in the state;
(3) "significant price update or modification" means (A) an increase or decrease of 10 percent or more in the pharmacy acquisition cost;
(B) a change in the methodology in which the maximum allowable cost for a drug is determined;
-5- Enrolled HB 226 (B) a change in the methodology in which the maximum allowable cost for a drug is determined;
6.
10.
AS 21.27.950 is repealed and reenacted to read:
Sec.
21.27.950.
Reimbursement.
(a) A pharmacy benefits manager shall reimburse a pharmacy or pharmacist for a drug in an amount not less than the national average drug acquisition cost for the drug on the date that the drug is administered or dispensed.
If the national average drug acquisition cost is not available at the time a drug is administered or dispensed, a pharmacy benefits manager shall reimburse in an amount that is not less than the wholesale acquisition cost of the drug.
If the wholesale acquisition cost of the drug is not available at the time a drug is administered or HB0226a -5- HB 226 New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B dispensed, a pharmacy benefits manager shall reimburse in an amount that is not less than the pharmacy acquisition cost of the drug.
(b) In addition to the reimbursement required under (a) of this section, a pharmacy benefits manager shall reimburse the pharmacy or pharmacist for a professional dispensing fee that is not less than the pharmacy dispensing fee applicable to providers in the state as listed in the Alaska Medicaid Fee Schedules and Covered Codes provided by the Department of Health on the date that the drug is administered or dispensed.
* Sec.
7.
Patient choice of pharmacy.
(a) An insurer providing a covered person with a health care insurance plan and its pharmacy benefits manager may not (1) prohibit or limit the person receiving pharmacy services under the insurer's health care insurance plan, including mail-order and specialty pharmacy services, from selecting a pharmacy of the person's choice to provide the pharmacy services if the pharmacy has notified the insurer, or the pharmacy benefits manager authorized to act on the insurer's behalf, of the pharmacy's agreement to accept as payment in full reimbursement for the pharmacy's services at rates applicable to pharmacies that are administered by the insurer or its pharmacy benefits manager, including any copayment required by the insurer's health care insurance plan;
or (2) restrict access to drugs by limiting distribution of a drug through an affiliate, except to the extent necessary to meet limited distribution requirements of the United States Food and Drug Administration or to ensure the appropriate dispensing of a drug that requires extraordinary special handling, provider coordination, or patient education when those requirements cannot be met by a network pharmacy;
an insurer or its pharmacy benefits manager who restricts drug access or limits drug distribution under the exceptions allowed by this paragraph shall, upon request, promptly provide a pharmacy or pharmacist with a complete written description of all extraordinary special handling, provider coordination, and patient education requirements necessary for the distribution or dispensing of a drug;
in this paragraph, "affiliate" means a business, pharmacy, pharmacist, or provider who, directly or indirectly through one or HB 226 -6- HB0226a New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B more intermediaries, controls, is controlled by, or is under common control with a pharmacy benefits manager.
(b) An insurer providing a covered person with a health carisurance plan and its pharmacy benefits manager shall permit a pharmacy or pharmacist to enter into a direct service agreement or network pharmacy agreement with the insurer or its pharmacy benefits manager if the pharmacy or pharmacist (1) meets the terms and conditions of participation in the direct service agreement or network pharmacy agreement;
(2) agrees to provide pharmacy services, including drugs, that meet the terms and conditions required under the insurer's health care insurance plan, including the terms of reimbursement;
and (3) not later than 30 days after being requested in writing to do so by the insurer or its pharmacy benefits manager, executes and delivers to the insurer or its pharmacy benefits manager the direct service agreement or network pharmacy agreement that the insurer or its pharmacy benefits manager requires of all its network pharmacies.
(c) An insurer or its pharmacy benefits manager shall act on a pharmacy's or pharmacist's request for a direct service agreement or a network pharmacy agreement not later than 30 days after the insurer or its pharmacy benefits manager receives the pharmacy's or pharmacist's request or, if the insurer or its pharmacy benefits manager requests supplemental information, 30 days after the insurer or its pharmacy benefits manager receives the supplemental information.
(d) A network pharmacy or a pharmacy applying to become a network pharmacy under this section shall be presumed to meet the requirements of a specialty pharmacy upon its assertion that it meets the requirements of a specialty pharmacy.
(e) In this section, (1) "specialty drug" means a drug that is subject to restricted distribution by the United States Food and Drug Administration;
(2) "specialty pharmacy" means a pharmacy capable of meeting the requirements of the United States Food and Drug Administration applicable to specialty drugs.
HB0226a -7- HB 226 New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B Sec.
21.27.952.
(a) An insurer or its pharmacy benefits manager may not (1) refuse to authorize, approve, or pay a provider for providing covered clinician-administered drugs and related services to a covered person if the provider has agreed to participate in the insurer's health care insurance plan according to the terms offered by the insurer or its pharmacy benefits manager;
(a) An insurer or its pharmacy benefits manager may not (1) refuse to authorize, approve, or pay a provider for providing covered clinician-administered drugs and related services to a covered person if the provider has agreed to participate in the insurer's health care insurance policy according to the terms offered by the insurer or its pharmacy benefits manager;
(2) if the criteria for medical necessity is met, condition, deny, restrict, refuse to authorize or approve, or reduce payment to a provider for a clinician- administered drug because the provider obtained the clinician-administered drug from a pharmacy that is not a network pharmacy in the insurer's or tis pharmacy benefits manager's network;
(2) if the criteria for medical necessity are met, condition, deny, restrict, or refuse to authorize or approve a provider for a clinician-administered drug because the provider obtained the clinician-administered drug from a pharmacy that is not a network pharmacy in the insurer's or its pharmacy benefits manager's network;
(3) impose coverage or benefit limitations or require a covered person to pay an additional fee, a higher or additional copay or coinsurance, or a penalty when obtaining a clinician-administered drug from a network pharmacy authorized under the laws of this state to dispense or administer the drug;
(3) require a pharmacy to dispense a clinician-administered drug directly to a covered person or agent of the insured with the intention that the covered person or the agent of the insured will transport the medication to a provider for administration;
(4) require a covered person to pay an additional fee, a highr e or additional copay or coinsurance, or another form of a price increase for a clinician- administered drug when the drug is not dispensed by a pharmacy or acquired from an entity selected by the insurer or its pharmacy benefits manager;
(4) require or encourage the dispensing of a clinician-administered drug to a covered person in a manner that is inconsistent with the supply chain security controls and chain of distribution set by 21 U.S.C.
(5) interfere with the right of a covered person to obtain a clinician- administered drug from the provider or pharmacy of the person's choice, including by inducement, steering, or offering or promoting financial or other incentives;
(6) limit or exclude coverage for a clinician-administered drug when not dispensed by a pharmacy or acquired from an entity selected by the insurer or its pharmacy benefits manager when the drug would otherwise be covered;
(7) require a pharmacy to dispense a clinician-administered drug directly to a covered person or agent of the insured with the intention that the covered person or the agent of the insured will transport the medication to a provider for administration;
(8) require or encourage the dispensing of a clinician-administered drug to a covered person in a manner that is inconsistent the supply chain security HB 226 -8- HB0226a New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B controls and chain of distribution set by 21 U.S.C.
(9) require that a clinician-administered drug be dispensed or administered to a covered person in the residence of the covered person or require use of an infusion site external to the office, department, or clinic of the provider of the covered person;
(5) require that a clinician-administered drug be dispensed or Enrolled HB 226 -6- administered to a covered person in the residence of the covered person or require use of an infusion site external to the office, department, or clinic of the provider of the covered person;
(b) In this section, "clinician-administered drug" means a drug, other than a vaccine, that requires administration by a provider and that the United States Food and Drug Administration or the drug's manufacturer has not approved for self- administration.
(b) If a health insurance policy provides in-network and out-of-network benefits and there is not an in-network health care provider or health care facility within a 50-mile radius of the primary residence of a covered person, the health insurance policy must provide coverage to the covered person for clinician- administered drugs at the minimum in-network benefit level.
(c) In this section, "clinician-administered drug" means a drug, other than a vaccine, that requires administration by a provider and that the United States Food and Drug Administration or the drug's manufacturer has not approved for self- administration.
21.27.953.
21.27.952.
In addition to any other penalty provided by law, if a person violates AS 21.27.945 - 21.27.955, the director may, after notice and hearing, impose a penalty in accordance with AS 21.27.440.
In addition to any other penalty provided by law, if a person violates AS 21.27.945 - 21.27.975, the director may, after notice and hearing, impose a penalty in accordance with AS 21.27.440.
Sec.
21.27.953.
Regulations relating to pharmacy benefits manager claims, grievances, activities, and appeals.
The director shall adopt regulations that provide standards and criteria for (1) the structure and operation of pharmacy benefits manager reimbursement of pharmacy claims under this chapter;
(2) procedures maintained by a pharmacy benefits manager to ensure that a pharmacy has the opportunity for appropriate resolution of grievances;
(3) an independent review of pharmacy benefits manager activities under this title;
and (4) requiring a pharmacy benefits manager to hear pricing appeals.
8.
11.
AS 21.27.955(4) is amended to read:
AS 21.27 is amended by adding a new section to article 9 to read:
(4) "list" means a [THE] list of [MULTI-SOURCE GENERIC] drugs for which a pharmacy benefits manager has established predetermined reimbursement amounts, or methods for determining reimbursement amounts, to be paid to a network pharmacy or pharmacist for pharmacy services, [AMOUNT HAS BEEN ESTABLISHED] such as a maximum allowable cost or maximum allowable cost list or any other list of prices used by a pharmacy benefits manager;
Sec.
* Sec.
21.27.975.
9.
Definitions.
AS 21.27.955(6) is repealed and reenacted to read:
In AS 21.27.901 - 21.27.975, (1) "affiliate" means a business, pharmacy, pharmacist, or pvider who, directly or indirectly through one or more intermediaries, controls, is controlled -7- Enrolled HB 226 by, or is under common control with a pharmacy benefits manager;
(6) "network pharmacy" means a pharmacy or pharmacist who, under a contract or agreement with the insurer or its pharmacy benefits manager, has agreed to provide pharmacy services to a covered person with an expectation of receiving payment, other than in-network coinsurance, copayments, or deductibles, directly or indirectly from the insurer;
(2) "audit" means an official examination and verification of accounts and records;
* Sec.
(3) "claim" means a request from a pharmacy or pharmacist to be reimbursed for the cost of filling or refilling a prescription for a drug or for providing a medical supply or device;
10.
(4) "covered person" means an individual receiving medication coverage or reimbursement provided by an insurer or its pharmacy benefits manager under a health care insurance policy;
AS 21.27.955 is amended by adding new paragraphs to read:
(5) "drug" means a prescription drug;
(11) "covered person" means an individual receiving medication coverage or reimbursement provided by an insurer or its pharmacy benefits manager HB0226a -9- HB 226 New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B under a health care insurance plan;
(6) "extrapolation" means the practice of inferring a frequency or dollar amount of overpayments, underpayments, invalid claims, or other errors on any portion of claims submitted, based on the frequency or dollar amount of overpayments, underpayments, invalid claims, or other errors actually measured in a sample of claims;
(12) "drug" means a prescription drug;
(7) "insurer" has the meaning given to "health care insurer"ni AS 21.54.500;
(13) "health care insurance plan" has the meaning given in AS 21.54.500;
(8) "list" means a list of drugs for which a pharmacy benefitsmanager has established predetermined reimbursement amounts, or methods for determining reimbursement amounts, to be paid to a network pharmacy or pharmacist for pharmacy services, such as a maximum allowable cost or maximum allowable cost list or any other list of prices used by a pharmacy benefits manager;
(14) "insurer" has the meaning given in AS 21.97.900 and includes a company or group of companies under common management, ownership, or control;
(9) "maximum allowable cost" means the maximum amount that a pharmacy benefits manager will reimburse a pharmacy for the cost of a drug;
(15) "maximum allowable cost" means the maximum amount that a pharmacy benefits manager will reimburse a pharmacy for the cost of a drug;
(10) "national average drug acquisition cost" means the average acquisition cost for outpatient drugs covered by Medicaid, as determined by a monthly survey of retail pharmacies conducted by the federal Centers for Medicare and Medicaid Services;
(16) "national average drug acquisition cost" means the average acquisition cost for outpatient drugs covered by Medicaid, as determined by a monthly survey of retail pharmacies conducted by the federal Centers for Medicare and Medicaid Services;
(11) "network" means an entity that, through contracts or agreements with providers, provides or arranges for access by groups of covered persons to health care services by providers who are not otherwise or individually contracted directly Enrolled HB 226 -8- with an insurer or its pharmacy benefits manager;
(17) "network" means an entity that, through contracts or agreements with providers, provides or arranges for access by groups of covered persons to health care services by providers who are not otherwise or individually contracted directly with an insurer or its pharmacy benefits manager;
(12) "network pharmacy" means a pharmacy that provides covered health care services or supplies to an insured or a member under a contract with a network plan to act as a participating provider;
(18) "provider" means a physician, pharmacist, hospital, clinic, hospital outpatient department, pharmacy under the common ownership or control of a provider, or other person licensed or otherwise authorized in this state to furnish health care services;
(13) "pharmacy" has the meaning given in AS 08.80.480;
(14) "pharmacy acquisition cost" means the amount that a pharmaceutical wholesaler or distributor charges for a pharmaceutical product as listed on the pharmacy's invoice;
(15) "pharmacy benefits manager" means a person that contracts with a pharmacy on behalf of an insurer to process claims or pay pharmacies for prescription drugs or medical devices and supplies or provide network management for pharmacies;
(16) "plan sponsor" has the meaning given in AS 21.54.500;
(17) "provider" means a physician, pharmacist, hospital, clinic, hospital outpatient department, pharmacy, or other person licensed or otherwise authorized in this state to furnish health care services;
(18) "recoupment" means the amount that a pharmacy must remit to a pharmacy benefits manager when the pharmacy benefits manager has determined that an overpayment to the pharmacy has occurred;
11.
12.
AS 21.36 is amended by adding a new section to read:
AS 21.36 is amended by adding a new section to article 5 to read:
21.36.126.
21.36.520.
(a) An insurer providing a health care insurance plan or its pharmacy benefits manager may not (1) violate AS 21.27.950;
(a) An insurer providing a health care insurance policy or its pharmacy benefits manager may not (1) interfere with a covered person's right to choose a pharmacy or provider;
(2) interfere with a covered person's right to choose a pharmacy or provider as provided in AS 21.27.951;
(2) interfere with a covered person's right of access to a liician- administered drug;
(3) interfere with a covered person's right of access to a cliician- administered drug as provided in AS 21.27.952;
(3) interfere with the right of a pharmacy or pharmacist trticipate as a network pharmacy;
(4) interfere with the right of a pharmacy or pharmacist torticipate HB 226 -10- HB0226a New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B as a network pharmacy as provided in AS 21.27.951;
(4) reimburse a pharmacy or pharmacist an amount less than the -9- Enrolled HB 226 amount the pharmacy benefits manager reimburses an affiliate for providing the same pharmacy services, calculated on a per-unit basis using the same generic product identifier or generic code number;
(5) reimburse a pharmacy or pharmacist an amount less than the amount the pharmacy benefits manager reimburses an affiliate for providing the same pharmacy services, calculated on a per-unit basis using the same generic product identifier or generic code number;
(5) impose a reduction in reimbursement for pharmacy services because of the person's choice among pharmacies that have agreed to participate in the plan according to the terms offered by the insurer or its pharmacy benefits manager;
(6) impose a copayment, fee, or condition that is not equally imposed on all individuals in the same benefit category, class, or copayment level, whether or not the benefits are furnished by a pharmacy or pharmacist who is not a network pharmacy;
(6) use a covered person's pharmacy services data collected under the provision of claims processing services for the purpose of soliciting, marketing, or referring the person to an affiliate of the pharmacy benefits manager;
(7) steer, invite, or direct a patient to use an affiliate's services through verbal or written communication, including (A) online messaging regarding the affiliate;
(7) prohibit or limit a pharmacy from mailing, shipping, or delivering drugs to a patient as an ancillary service;
or (B) patient- or prospective patient-specific advertising, marketing, or promotion of the affiliate;
however, the insurer or its pharmacy benefits manager (A) is not required to reimburse a delivery fee charged by a pharmacy unless the fee is specified in the contract between the pharmacy benefits manager and the pharmacy;
(8) impose any monetary advantage, inducement, or penalty that could affect or influence a person's choice among pharmacies that have agreed to participate in the plan according to the terms offered by the insurer or its pharmacy benefits manager, including a higher or additional copayment or fee or promotion of one participating pharmacy over another;
(B) may not require a patient signature as proof of delivery of a mailed or shipped drug if the pharmacy (i) maintains a mailing or shipping log signed by a representative of the pharmacy or keeps a record of each notification of delivery provided by the United States mail or a package delivery service;
(9) impose a reduction in reimbursement for pharmacy services because of the person's choice among pharmacies that have agreed to participate in the plan according to the terms offered by the insurer or its pharmacy benefits manager;
(10) use a covered person's pharmacy services data collected under the provision of claims processing services for the purpose of soliciting, marketing, or referring the person to an affiliate of the pharmacy benefits manager;
(11) require a covered person, as a condition of payment or reimbursement, to purchase pharmacist services or products, including drugs, through a mail-order pharmacy or pharmacy benefits manager affiliate;
(12) prohibit or limit a network pharmacy from mailing, shipping, or delivering drugs to a patient as an ancillary service;
however, the insurer or its pharmacy benefits manager HB0226a -11- HB 226 New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B (A) is not required to reimburse a delivery fee charged by a pharmacy unless the fee is specified in the contract between the pharmacy benefits manager and the pharmacy;
(B) may not require a patient signature as proof of delivery of a mailed or shipped drug if the network pharmacy (i) maintains a mailing or shipping log signed by a representative of the pharmacy or keeps a record of each notification of delivery provided by the United States mail or a package delivery service;
(13) impose on a pharmacist or pharmacy seeking to remain or become a network provider credentialing standards that are more strict than the licensing standards set by the Board of Pharmacy or charge a pharmacy a fee in connection with network enrollment;
(8) prohibit or limit a network pharmacy from informing an insured person of the difference between the out-of-pocket cost to the covered person to purchase a drug, medical device, or supply using the covered person's pharmacy benefits and the pharmacy's usual and customary charge for the drug, medical device, or supply;
(14) prohibit or limit a network pharmacy from informing an insured person of the difference between the out-of-pocket cost to the covered person to purchase a drug, medical device, or supply using the covered person's pharmacy benefits and the pharmacy's usual and customary charge for the drug, medical device, or supply;
(9) conduct or participate in spread pricing in the state;
(15) conduct or participate in spread pricing in the state;
(10) assess, charge, or collect a form of remuneration that passes from Enrolled HB 226 -10- a pharmacy or a pharmacist in a pharmacy network to the pharmacy benefits manager, including claim processing fees, performance-based fees, network participation fees, or accreditation fees;
(16) assess, charge, or collect a form of remuneration that passes from a pharmacy or a pharmacist in a pharmacy network to the pharmacy benefits manager including claim processing fees, performance-based fees, network participation fees, or accreditation fees.
(11) reverse and resubmit the claim of a pharmacy more than 90 days after the date the claim was first adjudicated, and may not reverse and resubmit the claim of a pharmacy unless the insurer or pharmacy benefits manager (A) provides prior written notification to the pharmacy;
(B) has just cause;
(C) first attempts to reconcile the claim with the pharmacy;
and (D) provides to the pharmacy, at the time of the reversal and resubmittal, a written description that includes details of and justification for the reversal and resubmittal.
HB 226 -12- HB0226a New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B (d) For purposes of this section, a violation has occurred each time a prohibited act is committed.
(d) For purposes of this section, a violation has occurred each time a prohibited act is committed.
(e) Nothing in this section may interfere with or violate a patient's right under AS 08.80.297 to know where the patient may have access to the lowest cost drugs or the requirement that a patient must receive notice of a change to a pharmacy network, including the addition of a new pharmacy or removal of an existing pharmacy from a pharmacy network.
(e) Nothing in this section may interfere with or violate a patient's right under AS 08.80.297 to know where the patient may have access to the lowest-cost drugs or the requirement that a patient must receive notice of a change to a pharmacy network, including the addition of a new pharmacy or removal of an existing pharmacy from a pharmacy network.
(f) In this section, (1) "affiliate" has the meaning given in AS 21.27.951(a)(2);
(f) The director may adopt regulations to provide an appeals process for claims adjudicated under this section.
(2) "clinician-administered drug" has the meaning given in AS 21.27.952(b);
(g) In this section, (1) "affiliate" has the meaning given in AS 21.27.975;
(3) "covered person" has the meaning given in AS 21.27.955;
(2) "clinician-administered drug" has the meaning given in AS 21.27.951(c);
(4) "drug" has the meaning given in AS 21.27.955;
(3) "covered person" has the meaning given in AS 21.27.975;
(5) "health care insurance plan" has the meaning given in AS 21.54.500;
-11- Enrolled HB 226 (4) "drug" has the meaning given in AS 21.27.975;
(6) "insurer" has the meaning given in AS 21.27.955;
(5) "insurer" has the meaning given to "health care insurer"ni AS 21.54.500;
(7) "mail-order pharmacy" means a pharmacy whose primary business is to receive drugs by mail or through electronic submission and to dispense medication to a covered person through the use of the United States mail or other common or contract carrier services and that may provide consultation with a covered person electronically rather than face-to-face;
(6) "network pharmacy" has the meaning given in AS 21.27.975;
(8) "network pharmacy" has the meaning given in AS 21.27.955;
(7) "out-of-pocket cost" means a deductible, coinsurance, copayment, or similar expense owed by a covered person under the terms of the covered person's health care insurance policy;
(9) "out-of-pocket cost" means a deductible, coinsurance, copayment, or similar expense owed by a covered person under the terms of the covered person's health care insurance plan;
(8) "provider" has the meaning given in AS 21.27.975;
(10) "provider" has the meaning given in AS 21.27.955;
(9) "spread pricing" means the method of pricing a drug in which the contracted price for a drug that a pharmacy benefits manager arges a health care insurance policy differs from the amount the pharmacy benefits manager directly or indirectly pays the pharmacist or pharmacy for pharmacist services.
(11) "spread pricing" means the method of pricing a drug in which the contracted price for a drug that a pharmacy benefits manager arges a health care insurance plan differs from the amount the pharmacy benefits manager directly or indirectly pays the pharmacist or pharmacy for pharmacist services.
12.
AS 29.10.200 is amended by adding a new paragraph to read:
HB0226a -13- HB 226 New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B (68) AS 29.20.420 (health care insurance plans).
* Sec.
AS 29.20 is amended by adding a new section to article 5 to read:
AS 21.27.950 and 21.27.955 are repealed.
Sec.
29.20.420.
Health care insurance plans.
(a) If a municipality offers a group health care insurance plan covering municipal employees, including by means of self-insurance, the municipal health care insurance plan, including the administration and management of pharmacy benefits under the plan, is subject to the requirements of AS 21.27.901 - 21.27.955 and AS 21.36.126.
(b) This section applies to home rule and general law municipalities.
(c) In this section, "health care insurance plan" has the meaning given in AS 21.54.500.
AS 39.30.090(a) is amended to read:
The uncodified law of the State of Alaska is amended by adding a new section to read:
(a) The Department of Administration may obtain a policy or policies of group insurance covering state employees, persons entitled to coverage under AS 14.25.168, 14.25.480, AS 22.25.090, AS 39.35.535, 39.35.880, or former AS 39.37.145, employees of other participating governmental units, or persons entitled to coverage under AS 23.15.136, subject to the following conditions:
APPLICABILITY.
(1) a group insurance policy shall provide one or more of the following benefits:
This Act applies to an insurance policy or contract, including a contract between a pharmacy benefits manager and a pharmacy orpharmacist, issued, delivered, entered into, renewed, or amended on or after the effective date of secs.
life insurance, accidental death and dismemberment insurance, weekly indemnity insurance, hospital expense insurance, surgical expense insurance, dental expense insurance, audiovisual insurance, or other medical care insurance;
1 - 13 of this Act.
(2) each eligible employee of the state, the spouse and the unmarried children chiefly dependent on the eligible employee for support, and each eligible employee of another participating governmental unit shall be covered by the group policy, unless exempt under regulations adopted by the commissioner of administration;
(3) a governmental unit may participate under a group policy if (A) its governing body adopts a resolution authorizing participation and payment of required premiums;
(B) a certified copy of the resolution is filed with the Department of Administration;
and (C) the commissioner of administration approves the HB 226 -14- HB0226a New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B participation in writing;
(4) in procuring a policy of group health or group life insurance as provided under this section or excess loss insurance as provided in AS 39.30.091, the Department of Administration shall comply with the dual choice requirements of AS 21.86.310, and shall obtain the insurance policy from an insurer authorized to transact business in the state under AS 21.09, a hospital or medical service corporation authorized to transact business in this state under AS 21.87, or a health maintenance organization authorized to operate in this state under AS 21.86;
an excess loss insurance policy may be obtained from a life or health insurer authorized to transact business in this state under AS 21.09 or from a hospital or medical service corporation authorized to transact business in this state under AS 21.87;
(5) the Department of Administration shall make available bid specifications for desired insurance benefits or for administration of benefit claims and payments to (A) all insurance carriers authorized to transact business in this state under AS 21.09 and all hospital or medical service corporations authorized to transact business under AS 21.87 who are qualified to provide the desired benefits;
and (B) insurance carriers authorized to transact business in this state under AS 21.09, hospital or medical service corporations authorized to transact business under AS 21.87, and third-party administrators licensed to transact business in this state and qualified to provide administrative services;
the specifications shall be made available at least once every five years;
the lowest responsible bid submitted by an insurance carrier, hospital or medical service corporation, or third-party administrator with adequate servicing facilities shall govern selection of a carrier, hospital or medical service corporation, or third-party administrator under this section or the selection of an insurance carrier or a hospital or medical service corporation to provide excess loss insurance as provided in AS 39.30.091;
(6) if the aggregate of dividends payable under the group insurance policy exceeds the governmental unit's share of the premium, the excess shall be applied by the governmental unit for the sole benefit of the employees;
(7) a person receiving benefits under AS 14.25.110, AS 22.25, AS 39.35, or former AS 39.37 may continue the life insurance verage that was in HB0226a -15- HB 226 New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B effect under this section at the time of termination of employment with the state or participating governmental unit;
(8) a person electing to have insurance under (7) of this subsection shall pay the cost of this insurance;
(9) for each permanent part-time employee electing coverage under this section, the state shall contribute one-half the state contribution rate for permanent full-time state employees, and the permanent part-time employee shall contribute the other one-half;
(10) a person receiving benefits under AS 14.25, AS 22.25, AS 39.35, or former AS 39.37 may obtain auditory, visual, and dental insurance for that person and eligible dependents under this section;
the level of coverage for persons over 65 shall be the same as that available before reaching age 65 except that the benefits payable shall be supplemental to any benefits provided under the federal old age, survivors, and disability insurance program;
a person electing to have insurance under this paragraph shall pay the cost of the insurance;
the commissioner of administration shall adopt regulations implementing this paragraph;
(11) a person receiving benefits under AS 14.25, AS 22.25, AS 39.35, or former AS 39.37 may obtain long-term care insurance for that person and eligible dependents under this section;
a person who elects insurance under this paragraph shall pay the cost of the insurance premium;
the commissioner of administration shall adopt regulations to implement this paragraph;
(12) each licensee holding a current operating agreement for a vending facility under AS 23.15.010 - 23.15.210 shall be covered by the group policy that applies to governmental units other than the state;
(13) a group health insurance policy covering employees of a participating governmental unit must meet the requirements of AS 21.27.901 - 21.27.955 and AS 21.36.126, including requirements relating to administration and management of pharmacy benefits under the policy.
AS 39.30.091 is amended to read:
The uncodified law of the State of Alaska is amended by adding a new section to read:
Sec.
TRANSITION:
39.30.091.
REGULATIONS.
Authorization for self-insurance and excess loss insurance.
The director of the division of insurance may adopt regulations necessary to implement the changes made by this Act under AS 21.06.090.
Notwithstanding AS 21.86.310 or AS 39.30.090, the Department of Administration HB 226 -16- HB0226a New Text Underlined [DELETED TEXT BRACKETED] 33-LS0955\B may provide, by means of self-insurance, one or more of the benefits listed in AS 39.30.090(a)(1) for state employees eligible for the benefits by law or under a collective bargaining agreement and for persons receiving benefits under AS 14.25, AS 22.25, AS 39.35, or former AS 39.37, and their dependents.
The regulations take effect under AS 44.62 (Administrative Procedure Act), but not before the effective date of the law implemented by the regulation.
The department shall procure any necessary excess loss insurance under AS 39.30.090.
A self-insured group medical plan covering active state employees provided under this section is subject to the requirements of AS 21.27.901 - 21.27.955 and AS 21.36.126, including requirements relating to administration and management of pharmacy benefits under the plan.
AS 45.50.471(b) is amended by adding a new paragraph to read:
Section 15 of this Act takes effect immediately under AS 01.10.070(c).
(58) violating AS 21.36.126(a) (insurers and pharmacy benefits managers), if the violation is committed or performed with a frequency that indicates a general business practice.
AS 21.27.901(b)(3), 21.27.901(b)(4), and 21.27.955(5) are repealed.
Except as provided in sec.
* Sec.
16 of this Act, this Act takes effect January 1, 2025.
18.
Enrolled HB 226 -12-
The uncodified law of the State of Alaska is amended by adding a new section to read:
APPLICABILITY.
This Act applies to a contract between a pharmy acbenefits manager and a pharmacy or pharmacist entered into, renewed, or amended on or after the effective date of this Act.
* Sec.
19.
This Act takes effect July 1, 2024.
HB0226a -17- HB 226 New Text Underlined [DELETED TEXT BRACKETED]
View plain text versions (5)

Action History

  1. (H) EFFECTIVE DATE(S) OF LAW SEE CHAPTER

  2. (H) Signed into law 9/23 CHAPTER 61 SLA 24

  3. (H) MANIFEST ERROR(S)

  4. (H) 4:10 P.M. 9/12/24 Transmitted to Governor

  5. (H) EFFECTIVE DATE(S) SAME AS PASSAGE

  6. (H) CONCURRED AM OF (S) Y33 N5 E1 A1

  7. (H) CONCUR TAKEN UP

  8. (H) CONCUR READ AND HELD

  9. (S) VERSION: SCS CSHB 226(L&C)

  10. (S) TRANSMITTED TO (H) AS AMENDED

  11. (S) EFFECTIVE DATE(S) SAME AS PASSAGE

  12. (S) PASSED Y19 N- E1

  13. (S) READ THE THIRD TIME SCS CSHB 226(L&C)

  14. (S) ADVANCED TO THIRD READING UC

  15. (S) L&C SCS ADOPTED UC

  16. (S) READ THE SECOND TIME

  17. (S) RULES TO CALENDAR 5/11/2024

  18. (S) FN6: ZERO(CED)

  19. (S) FN5: ZERO(CED)

  20. (S) FN4: ZERO(ADM)

  21. (S) NR: MERRICK

  22. (S) DP: BJORKMAN, DUNBAR, GRAY-JACKSON

  23. (S) L&C RPT SCS 3DP 1NR SAME TITLE

  24. (S) Moved SCS CSHB 226(L&C) Out of Committee -- Please Note Time Change --

  25. (S) LABOR & COMMERCE at 05:15 PM BELTZ 105 (TSBldg)

  26. (S) Minutes (SL&C)

  27. (S) Heard & Held

  28. (S) LABOR & COMMERCE at 01:30 PM BELTZ 105 (TSBldg)

  29. (S) CROSS SPONSOR(S): MYERS

  30. (S) L&C

  31. (S) READ THE FIRST TIME - REFERRALS

  32. (H) VERSION: CSHB 226(L&C)

  33. (H) TRANSMITTED TO (S)

  34. (H) EFFECTIVE DATE(S) SAME AS PASSAGE

  35. (H) PASSED Y30 N7 E1 A2

  36. (H) READ THE THIRD TIME CSHB 226(L&C)

  37. (H) COSPONSOR(S): JOSEPHSON

  38. (H) ADVANCED TO THIRD READING 5/3 CALENDAR

  39. (H) AM NO 11 NOT OFFERED

  40. (H) AM NO 10 FAILED Y13 N26 A1

  41. (H) AM NO 9 FAILED Y7 N32 A1

  42. (H) AM NO 8 NOT OFFERED

  43. (H) AM NO 7 FAILED Y13 N26 A1

  44. (H) AM NO 6 FAILED Y5 N35

  45. (H) AM NO 5 FAILED Y6 N34

  46. (H) AM NO 4 FAILED Y4 N36

  47. (H) AM NO 3 FAILED Y2 N38

  48. (H) AM NO 2 FAILED Y2 N37 A1

  49. (H) AM NO 1 FAILED Y19 N20 A1

  50. (H) L&C CS ADOPTED Y37 N3

  51. (H) READ THE SECOND TIME

  52. (H) RULES TO CALENDAR 5/2/2024

  53. (S) Minutes (SL&C)

  54. (S) <Pending Referral>

  55. (S) LABOR & COMMERCE at 01:30 PM BELTZ 105 (TSBldg)

  56. (H) COSPONSOR(S): GALVIN

  57. (H) FIN REFERRAL REMOVED

  58. (H) FN6: ZERO(CED)

  59. (H) FN5: ZERO(CED)

  60. (H) FN4: ZERO(ADM)

  61. (H) NR: FIELDS

  62. (H) DNP: PRAX

  63. (H) DP: WRIGHT, CARRICK, SADDLER, RUFFRIDGE

  64. (H) L&C RPT CS(L&C) NEW TITLE 4DP 1DNP 1NR

  65. (H) Minutes (HL&C)

  66. (H) Moved CSHB 226(L&C) Out of Committee

  67. (H) LABOR & COMMERCE at 03:15 PM BARNES 124

  68. (H) COSPONSOR(S): RUFFRIDGE

  69. (H) Heard & Held

  70. (H) LABOR & COMMERCE at 03:15 PM BARNES 124

  71. (H) COSPONSOR(S): WRIGHT

  72. (H) -- MEETING CANCELED --

  73. (H) LABOR & COMMERCE at 03:15 PM BARNES 124

  74. (H) Minutes (HL&C)

  75. (H) <Bill Hearing Rescheduled to 04/05/24>

  76. (H) LABOR & COMMERCE at 03:15 PM BARNES 124

  77. (H) Minutes (HL&C)

  78. (H) LABOR & COMMERCE at 03:15 PM BARNES 124

  79. (H) COSPONSOR(S): ORTIZ

  80. (H) Minutes (HL&C)

  81. (H) Heard & Held

  82. (H) LABOR & COMMERCE at 03:15 PM BARNES 124

  83. (H) COSPONSOR(S): HIMSCHOOT

  84. (H) Minutes (HL&C)

  85. (H) Heard & Held

  86. (H) LABOR & COMMERCE at 03:15 PM BARNES 124

  87. (H) Minutes (HL&C)

  88. (H) Scheduled but Not Heard

  89. (H) LABOR & COMMERCE at 03:15 PM BARNES 124

  90. (H) FN3: (CED)

  91. (H) FN2: (CED)

  92. (H) FN1: (ADM)

  93. (H) NR: FIELDS

  94. (H) DP: SUMNER, RUFFRIDGE, MCCORMICK, SADDLER, MINA, PRAX

  95. (H) HSS RPT CS(HSS) 6DP 1NR

  96. (H) Minutes (HHSS)

  97. (H) Moved CSHB 226(HSS) Out of Committee

  98. (H) HEALTH & SOCIAL SERVICES at 03:00 PM DAVIS 106

  99. (H) Minutes (HHSS)

  100. (H) Heard & Held

  101. (H) HEALTH & SOCIAL SERVICES at 03:00 PM DAVIS 106

  102. (H) HSS, L&C, FIN

  103. (H) READ THE FIRST TIME - REFERRALS

  104. (H) Prefile released 1/8/24

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 7 co-sponsors · 57 not signed on

Sponsors (1)

  • Sumner

Not signed on (57)

57 members have not signed on to this bill.

Show all 57 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 226?
HB 226 is sponsored by Robert Myers (R), Wright, Justin Ruffridge (R), Ortiz, Andy Josephson (D), Rebecca Himschoot (N), Alyse Galvin (N), and Sumner.
What is the current status of HB 226?
This bill has been enacted into law. Introduced January 16, 2024. Enacted.
Where can I track HB 226?
Track HB 226 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 226

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 226

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →